At a time when the world is scrambling to invent a vaccine for coronavirus, the Food and Drug Administration has approved a drug called “Teicoplanin” is a possible drug and more powerful to combat against covid-19, research found by Indian Institute of Technology (IIT), Delhi In their phenomenal research and quest for finding a vaccine, Kusuma School of Biological Sciences, the research wing of the IIT Delhi, screened an assemblage of 23 approved drugs, gave leads towards being therapeutic options for coronavirus.
When compared to other drugs currently in use, Teicoplanin was found to be 20 times far more effective than the drugs used against SARS-CoV-2, such as Lopinavir and Hydroxychloroquine in our laboratory condition said Ashok Patel, Professor at IIT Delhi. The findings of the research have also been published in the international journal of Biological Macromolecules. And this drug regularly used for treating Gram-positive bacterial infections with low toxicity profiles in humans.
Various clinical studies have been carried out Teicoplanin at the University of Sapienza in Rome. Nonetheless, a more detailed clinical investigation is required on a large cohort, in different stages mild, moderate, and critically ill patients to conclude the definite role of Teicoplanin against COVID-19,” Patel said.
More than 3.2 crore people have been infected globally with Covid-19 and the total number of deaths from the deadly virus now touching to one million. India’s coronavirus tally galloped past 63 lakh on Tuesday with 70,589 new cases, while the recovery rate is 82 percent and the death toll mounted to 97,497 mark, the Health Ministry said.
Get 30% OFF on Dynamic Website Design